Cargando…
Limitations of Systemic Oncological Therapy in Breast Cancer Patients with Chronic Kidney Disease
Breast cancer is the most common malignancy, affecting middle-age and older women frequently suffering from other chronic diseases, including chronic kidney disease. The risk of breast cancer development in women on renal replacement therapy (peritoneal dialysis and haemodialysis) is higher than in...
Autores principales: | Bednarek, Anna, Mykała-Cieśla, Joanna, Pogoda, Katarzyna, Jagiełło-Gruszfeld, Agnieszka, Kunkiel, Michał, Winder, Mateusz, Chudek, Jerzy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251456/ https://www.ncbi.nlm.nih.gov/pubmed/32508921 http://dx.doi.org/10.1155/2020/7267083 |
Ejemplares similares
-
Intracranial Response Rate in Patients with Breast Cancer Brain Metastases after Systemic Therapy
por: Niwinska, Anna, et al.
Publicado: (2022) -
Locally Advanced Adenoid Cystic Carcinoma of the Breast—A Case Report with a Review of the Literature
por: Rypel, Joanna, et al.
Publicado: (2023) -
Eligibility criteria in clinical trials in breast cancer: a cohort study
por: Szlezinger, Katarzyna, et al.
Publicado: (2023) -
Effects of BRCA Germline Mutations on Triple-Negative Breast Cancer Prognosis
por: Pogoda, Katarzyna, et al.
Publicado: (2020) -
Neoadjuvant Pertuzumab Plus Trastuzumab in Combination with Docetaxel and Carboplatin in Patients with HER2-Positive Breast Cancer: Real-World Data from the National Institute of Oncology in Poland
por: Jagiełło-Gruszfeld, Agnieszka Irena, et al.
Publicado: (2022)